News

Anabolic Antiosteoporotic Treatment as a First Step in Patients with Very High Fracture Risk

18. 1. 2024 Source: Osteoporosis – Trends in Sequential Therapy

According to the 2022 opinion of the ESCEO (European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases) working group, it is advisable to identify patients with osteoporosis who have a very high risk of fracture and to use an anabolic antiosteoporotic drug as the initial pharmacotherapeutic intervention, followed by necessary antiresorptive treatment to be addressed over the entire expected length of life.

Cardio-renal-metabolic syndrome in context

The increase in the incidence of type 2 diabetes mellitus (T2DM), cardiovascular diseases (CVD), and chronic kidney disease (CKD) ranks among the most significant health issues of our time. Based on recent...

16. 1. 2024 Source: Heart Failure

MUDr. Petra Garnolová: The combination of medical cannabis with other analgesics is the ideal way to achieve the best effect with the fewest side effects

Medical cannabis is gradually finding its way to many patients with various ailments, including those with unmanageable and hard-to-influence chronic pain. For them, this therapy can offer a new…

8. 1. 2024 Source: Medical Cannabis

Calculator Naxiva -⁠ Application for Easy Prescription of Medical Cannabis Extracts

The new Calculator Naxiva application, specifically designed for doctors prescribing medical cannabis, allows for a simple conversion of its doses to the Naxiva Panaxol extract. Quickly and easily,…

8. 1. 2024 Source: Medical Cannabis

A Decade of Therapy Targeting B Lymphocytes in MS

Ocrelizumab is not only a pioneer but also a highly effective and still promising modality for the treatment of multiple sclerosis (MS) with excellent patient adherence and persistence.

3. 1. 2024 Source: Neurology - Multiple Sclerosis

Diagnosis and Management of Interstitial Lung Processes Associated with Rheumatoid Arthritis

Interstitial lung processes (ILD) are common yet insufficiently diagnosed complications of rheumatoid arthritis (RA), significantly increasing the morbidity and mortality of patients. ILD can occur…

3. 1. 2024 Source: Progressive Interstitial Pulmonary Processes

Potential of Enoxaparin to Maintain A-V Shunt Patency According to the SEP Protocol

A newly published study by authors from Singapore focused on the ability of the SEP protocol –⁠ short-term low-dose enoxaparin administration based on body weight –⁠ to maintain the patency of an…

3. 1. 2024 Source: Thromboprophylaxis

How to Navigate the Challenges of Anticoagulant Therapy in Pregnant Women −⁠ A Case Study

Every carrier of a mechanical heart valve is also on anticoagulant therapy. Warfarin is most commonly used for this purpose, but it is not suitable during pregnancy due to the risk of embryopathy. So…

3. 1. 2024 Source: Thromboprophylaxis

Position of Enoxaparin and DOACs in Extended Prevention of VTE After Surgeries for Gynecological Malignancies

The prophylaxis of venous thromboembolism is a crucial part of postoperative management in oncological diseases, including gynecological malignancies. A newly published survey study conducted in…

3. 1. 2024 Source: Thromboprophylaxis

Issues of Adherence to Thromboprophylaxis with Enoxaparin in Patients with Sickle Cell Disease

Thromboembolic disease is one of the common complications in patients with sickle cell disease (SCD). However, a recently published study shows that patient adherence to prescribed thromboprophylaxis…

3. 1. 2024 Source: Thromboprophylaxis

Chairwoman of Revma Liga ČR: I Hope We Improve Our Approach and Treatment of Osteoporosis in the Czech Republic

Patients with inflammatory rheumatic diseases have a significantly increased risk of developing osteoporosis and related fractures. At the same time, this disease is considerably underestimated in…

20. 12. 2023 Source: Osteoporosis – Trends in Sequential Therapy

MUDr. Libor Dvořáček: Microinvasiveness of surgery involves not only the method but also targeted solutions to varicose vein sources

Varicose veins, or chronic venous insufficiency of the lower extremities, are primarily a health issue, not purely a cosmetic one. This is because they are associated with the risk of complications…

17. 12. 2023 Source: Venous Insufficiency

MUDr. Petr Majtan: Venofarmaka should receive at least partial coverage for hemorrhoidal disease −⁠ their benefit in this indication is clear

What is the use of venofarmaka before and after surgery for chronic venous disease (CVD), and what effects of this treatment does he observe in daily practice with his patients? We asked MUDr. Petr…

17. 12. 2023 Source: Venous Insufficiency

Wound Healing and Exudate –⁠ A Comprehensive Look at Moisture Management in Wounds

Exudate produced during the inflammatory phase of healing is a crucial factor that ensures a moist environment in the wound, provides nutrients for cellular metabolism, and supports autolytic…

14. 12. 2023 Source: Wound Healing

Effective antiosteoporotics from the aminobisphosphonate group can finally be prescribed by general practitioners from January 2024

Osteoporosis represents a serious societal problem generating numerous health and social complications as well as considerable economic costs. In the Czech Republic, it is estimated to affect 500−750…

12. 12. 2023 Source: Treatment of Osteoporosis

1 … 16 17 18 19 20 … 115

Back Filter by speciality

Remove filters

Popular this week